Cargando…

Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru

BACKGROUND: Multidrug-resistant tuberculosis poses a major threat to the success of tuberculosis control programs worldwide. Understanding how drug-resistant tuberculosis evolves can inform the development of new therapeutic and preventive strategies. METHODS: Here, we use novel genome-wide analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandjean, Louis, Gilman, Robert H., Iwamoto, Tomatada, Köser, Claudio U., Coronel, Jorge, Zimic, Mirko, Török, M. Estee, Ayabina, Diepreye, Kendall, Michelle, Fraser, Christophe, Harris, Simon, Parkhill, Julian, Peacock, Sharon J., Moore, David A. J., Colijn, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744980/
https://www.ncbi.nlm.nih.gov/pubmed/29281674
http://dx.doi.org/10.1371/journal.pone.0189838
_version_ 1783288847505817600
author Grandjean, Louis
Gilman, Robert H.
Iwamoto, Tomatada
Köser, Claudio U.
Coronel, Jorge
Zimic, Mirko
Török, M. Estee
Ayabina, Diepreye
Kendall, Michelle
Fraser, Christophe
Harris, Simon
Parkhill, Julian
Peacock, Sharon J.
Moore, David A. J.
Colijn, Caroline
author_facet Grandjean, Louis
Gilman, Robert H.
Iwamoto, Tomatada
Köser, Claudio U.
Coronel, Jorge
Zimic, Mirko
Török, M. Estee
Ayabina, Diepreye
Kendall, Michelle
Fraser, Christophe
Harris, Simon
Parkhill, Julian
Peacock, Sharon J.
Moore, David A. J.
Colijn, Caroline
author_sort Grandjean, Louis
collection PubMed
description BACKGROUND: Multidrug-resistant tuberculosis poses a major threat to the success of tuberculosis control programs worldwide. Understanding how drug-resistant tuberculosis evolves can inform the development of new therapeutic and preventive strategies. METHODS: Here, we use novel genome-wide analysis techniques to identify polymorphisms that are associated with drug resistance, adaptive evolution and the structure of the phylogenetic tree. A total of 471 samples from different patients collected between 2009 and 2013 in the Lima suburbs of Callao and Lima South were sequenced on the Illumina MiSeq platform with 150bp paired-end reads. After alignment to the reference H37Rv genome, variants were called using standardized methodology. Genome-wide analysis was undertaken using custom written scripts implemented in R software. RESULTS: High quality homoplastic single nucleotide polymorphisms were observed in genes known to confer drug resistance as well as genes in the Mycobacterium tuberculosis ESX secreted protein pathway, pks12, and close to toxin/anti-toxin pairs. Correlation of homoplastic variant sites identified that many were significantly correlated, suggestive of epistasis. Variation in genes coding for ESX secreted proteins also significantly disrupted phylogenetic structure. Mutations in ESX genes in key antigenic epitope positions were also found to disrupt tree topology. CONCLUSION: Variation in these genes have a biologically plausible effect on immunogenicity and virulence. This makes functional characterization warranted to determine the effects of these polymorphisms on bacterial fitness and transmission.
format Online
Article
Text
id pubmed-5744980
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57449802018-01-08 Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru Grandjean, Louis Gilman, Robert H. Iwamoto, Tomatada Köser, Claudio U. Coronel, Jorge Zimic, Mirko Török, M. Estee Ayabina, Diepreye Kendall, Michelle Fraser, Christophe Harris, Simon Parkhill, Julian Peacock, Sharon J. Moore, David A. J. Colijn, Caroline PLoS One Research Article BACKGROUND: Multidrug-resistant tuberculosis poses a major threat to the success of tuberculosis control programs worldwide. Understanding how drug-resistant tuberculosis evolves can inform the development of new therapeutic and preventive strategies. METHODS: Here, we use novel genome-wide analysis techniques to identify polymorphisms that are associated with drug resistance, adaptive evolution and the structure of the phylogenetic tree. A total of 471 samples from different patients collected between 2009 and 2013 in the Lima suburbs of Callao and Lima South were sequenced on the Illumina MiSeq platform with 150bp paired-end reads. After alignment to the reference H37Rv genome, variants were called using standardized methodology. Genome-wide analysis was undertaken using custom written scripts implemented in R software. RESULTS: High quality homoplastic single nucleotide polymorphisms were observed in genes known to confer drug resistance as well as genes in the Mycobacterium tuberculosis ESX secreted protein pathway, pks12, and close to toxin/anti-toxin pairs. Correlation of homoplastic variant sites identified that many were significantly correlated, suggestive of epistasis. Variation in genes coding for ESX secreted proteins also significantly disrupted phylogenetic structure. Mutations in ESX genes in key antigenic epitope positions were also found to disrupt tree topology. CONCLUSION: Variation in these genes have a biologically plausible effect on immunogenicity and virulence. This makes functional characterization warranted to determine the effects of these polymorphisms on bacterial fitness and transmission. Public Library of Science 2017-12-27 /pmc/articles/PMC5744980/ /pubmed/29281674 http://dx.doi.org/10.1371/journal.pone.0189838 Text en © 2017 Grandjean et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Grandjean, Louis
Gilman, Robert H.
Iwamoto, Tomatada
Köser, Claudio U.
Coronel, Jorge
Zimic, Mirko
Török, M. Estee
Ayabina, Diepreye
Kendall, Michelle
Fraser, Christophe
Harris, Simon
Parkhill, Julian
Peacock, Sharon J.
Moore, David A. J.
Colijn, Caroline
Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru
title Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru
title_full Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru
title_fullStr Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru
title_full_unstemmed Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru
title_short Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru
title_sort convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in peru
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744980/
https://www.ncbi.nlm.nih.gov/pubmed/29281674
http://dx.doi.org/10.1371/journal.pone.0189838
work_keys_str_mv AT grandjeanlouis convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT gilmanroberth convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT iwamototomatada convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT koserclaudiou convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT coroneljorge convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT zimicmirko convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT torokmestee convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT ayabinadiepreye convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT kendallmichelle convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT fraserchristophe convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT harrissimon convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT parkhilljulian convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT peacocksharonj convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT mooredavidaj convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu
AT colijncaroline convergentevolutionandtopologicallydisruptivepolymorphismsamongmultidrugresistanttuberculosisinperu